CAITLIN POWERS: Open Payments
NPI 1881159945 · LUTHERVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,707 in 71 payments from 16 companies in 2025. Trend: 2023 $2,574 · 2024 $1,721 · 2025 $1,707
Food & beverage: $1,707
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 6 | $262 |
| Galderma Laboratories, L.P. | 8 | $214 |
| Novartis Pharmaceuticals Corporation | 11 | $202 |
| ABBVIE INC. | 12 | $179 |
| Arcutis Biotherapeutics, Inc. | 3 | $162 |
| Organon LLC | 5 | $113 |
| LEO Pharma Inc. | 4 | $110 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $99 |
| Lilly USA, LLC | 3 | $76 |
| Regeneron Healthcare Solutions, Inc. | 3 | $68 |
Products named: DUPIXENT, NEMLUVIO, Zoryve, COSENTYX, SKYRIZI, ILUMYA, ADBRY, RINVOQ.
Industry payments across MD — which companies pay providers there.
